These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1134191)

  • 41. Diphenylhydantoin: placental transport, fetal localization, neonatal metabolism, and possible teratogenic effects.
    Mirkin BL
    J Pediatr; 1971 Feb; 78(2):329-37. PubMed ID: 5539782
    [No Abstract]   [Full Text] [Related]  

  • 42. Microsomal enzyme inducers and hypervitaminosis A in rats.
    Tuchweber B; Garg BD; Salas M
    Arch Pathol Lab Med; 1976 Feb; 100(2):100-5. PubMed ID: 946392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biliary excretion of diphenylhydantoin in the rat. Time-course studies.
    Inaba T; Umeda T
    Drug Metab Dispos; 1975; 3(2):69-73. PubMed ID: 236160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of microsomal phenytoin metabolism by nafimidone and related imidazoles. Potency and structural considerations.
    Kapetanovic IM; Kupferberg HJ
    Drug Metab Dispos; 1985; 13(4):430-7. PubMed ID: 2863106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereochemical aspects of 1,3-butadiene metabolism and toxicity in rat and mouse liver microsomes and freshly isolated rat hepatocytes.
    Nieusma JL; Claffey DJ; Maniglier-Poulet C; Imiolczyk T; Ross D; Ruth JA
    Chem Res Toxicol; 1997 Apr; 10(4):450-6. PubMed ID: 9114983
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical implications of certain aspects of diphenylhydantoin metabolism.
    Bochner F; Hooper W; Tyrer J; Eadie M
    Proc Aust Assoc Neurol; 1973; 9():171-8. PubMed ID: 4719398
    [No Abstract]   [Full Text] [Related]  

  • 47. Kinetic and spectral studies of type I and type II compounds with rat hepatic microsomes in the presence of the major metabolite of diphenylhydantoin.
    Stavchansky SA; Kostenbauder HB; Lubawy WC
    Drug Metab Dispos; 1975; 3(6):557-64. PubMed ID: 1233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diphenylhydantoin stimulation of various pathways of hepatic microsomal drug metabolism in rabbits.
    Gut I; Becker BA
    Acta Univ Carol Med (Praha); 1980; 26(1-2):105-14. PubMed ID: 7315667
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of diazepam on the biliary excretion of diphenylhydantoin in the rat.
    El-Hawari AM; Plaa GL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):14-25. PubMed ID: 850136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of diphenylhydantoin on the hepatic microsomal ethanol oxidizing system in the rat.
    Andreasen PB; Bremmelgaard A
    Pharmacology; 1974; 12(4-5):237-43. PubMed ID: 4449887
    [No Abstract]   [Full Text] [Related]  

  • 51. Phenytoin metabolism in the rat. Pharmacokinetic correlation between in vitro hepatic microsomal enzyme activity and in vivo elimination kinetics.
    Collins JM; Blake DA; Egner PG
    Drug Metab Dispos; 1978; 6(3):251-7. PubMed ID: 26545
    [No Abstract]   [Full Text] [Related]  

  • 52. Kinetic changes in microsomal drug metabolism with age and diphenylhydantoin treatment.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    Eur J Pharmacol; 1970 Jul; 11(1):101-8. PubMed ID: 4393448
    [No Abstract]   [Full Text] [Related]  

  • 53. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
    Witherow LE; Houston JB
    J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)].
    Remmer H; Hirschmann J; Greiner I
    Dtsch Med Wochenschr; 1969 Jun; 94(24):1265-72. PubMed ID: 5771073
    [No Abstract]   [Full Text] [Related]  

  • 55. Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.
    Doecke CJ; Veronese ME; Pond SM; Miners JO; Birkett DJ; Sansom LN; McManus ME
    Br J Clin Pharmacol; 1991 Feb; 31(2):125-30. PubMed ID: 2049228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro binding of (4-14C)diphenylhydantoin to rat brain microsomes.
    Hadfield MG; Bosworth JE
    Brain Res; 1974 May; 71(1):183-6. PubMed ID: 4821420
    [No Abstract]   [Full Text] [Related]  

  • 57. A comparison of diphenylhydantoin metabolism in different tissues using high performance liquid chromatography.
    MacKinney AA; Shinnick FL; Gorder C
    Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):395-411. PubMed ID: 7122986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat.
    Wesseling H; Thurkow I; Mulder G
    Biochem Pharmacol; 1973 Dec; 22(23):3033-40. PubMed ID: 4761563
    [No Abstract]   [Full Text] [Related]  

  • 59. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible mechanisms for the pharmacokinetic interaction between phenytoin and folinate in rats.
    Yamasaki D; Tsujimoto M; Ohdo S; Ohtani H; Sawada Y
    Ther Drug Monit; 2007 Aug; 29(4):404-11. PubMed ID: 17667793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.